TKT and non-small cell lung carcinoma: A Phase II trial investigated the efficacy of intratumoral injection of oncolytic virus ADV/HSV-tk followed by stereotactic body radiotherapy (SBRT) at the same tumor site in patients with stage IV non-small cell lung cancer (NSCLC), including those who were treatment-naïve or resistant to prior PD-1 therapy.